S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
Critical asset just had biggest fall on record (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
Critical asset just had biggest fall on record (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
Critical asset just had biggest fall on record (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
Palantir Stock Has It all… Except the Analysts' Support
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
3 wealth-compounding stocks to beat the market this decade
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
2 Navigation Stocks That Continue to Defy Gravity
Workday Stock Price is Working on a Buy-the-Dip Opportunity
Critical asset just had biggest fall on record (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
Applied Optoelectronics earnings dumper, pain now for gain later?

Addus HomeCare (ADUS) Competitors

$91.85
-0.25 (-0.27%)
(As of 02/28/2024 ET)

ADUS vs. BTSG, AHCO, EHAB, AVAH, AMED, OPCH, SLNO, PRTA, STAA, and AGIO

Should you be buying Addus HomeCare stock or one of its competitors? The main competitors of Addus HomeCare include BrightSpring Health Services (BTSG), AdaptHealth (AHCO), Enhabit (EHAB), Aveanna Healthcare (AVAH), Amedisys (AMED), Option Care Health (OPCH), Soleno Therapeutics (SLNO), Prothena (PRTA), STAAR Surgical (STAA), and Agios Pharmaceuticals (AGIO). These companies are all part of the "medical" sector.

Addus HomeCare vs.

BrightSpring Health Services (NASDAQ:BTSG) and Addus HomeCare (NASDAQ:ADUS) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, dividends, valuation, analyst recommendations, community ranking and media sentiment.

Addus HomeCare received 280 more outperform votes than BrightSpring Health Services when rated by MarketBeat users. However, 85.71% of users gave BrightSpring Health Services an outperform vote while only 66.97% of users gave Addus HomeCare an outperform vote.

CompanyUnderperformOutperform
BrightSpring Health ServicesOutperform Votes
12
85.71%
Underperform Votes
2
14.29%
Addus HomeCareOutperform Votes
292
66.97%
Underperform Votes
144
33.03%

Addus HomeCare has higher revenue and earnings than BrightSpring Health Services.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrightSpring Health ServicesN/AN/AN/AN/AN/A
Addus HomeCare$1.06B1.41$46.03M$3.8423.92

Addus HomeCare has a net margin of 5.91% compared to Addus HomeCare's net margin of 0.00%. BrightSpring Health Services' return on equity of 9.85% beat Addus HomeCare's return on equity.

Company Net Margins Return on Equity Return on Assets
BrightSpring Health ServicesN/A N/A N/A
Addus HomeCare 5.91%9.85%6.80%

95.3% of Addus HomeCare shares are owned by institutional investors. 4.4% of Addus HomeCare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, BrightSpring Health Services had 11 more articles in the media than Addus HomeCare. MarketBeat recorded 26 mentions for BrightSpring Health Services and 15 mentions for Addus HomeCare. BrightSpring Health Services' average media sentiment score of 1.26 beat Addus HomeCare's score of 0.44 indicating that Addus HomeCare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BrightSpring Health Services
4 Very Positive mention(s)
4 Positive mention(s)
11 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Addus HomeCare
7 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

BrightSpring Health Services currently has a consensus target price of $16.39, suggesting a potential upside of 68.44%. Addus HomeCare has a consensus target price of $107.00, suggesting a potential upside of 16.49%. Given Addus HomeCare's higher probable upside, equities analysts plainly believe BrightSpring Health Services is more favorable than Addus HomeCare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
3.00
Addus HomeCare
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Addus HomeCare beats BrightSpring Health Services on 8 of the 12 factors compared between the two stocks.


Get Addus HomeCare News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADUS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ADUS vs. The Competition

MetricAddus HomeCareHome health care services IndustryMedical SectorNASDAQ Exchange
Market Cap$1.49B$3.29B$4.99B$7.47B
Dividend YieldN/A0.27%2.86%3.87%
P/E Ratio23.9221.23274.2318.52
Price / Sales1.411.563,087.4469.82
Price / Cash20.9713.7494.8554.69
Price / Book2.343.644.454.67
Net Income$46.03M$96.99M$113.13M$211.02M
7 Day Performance2.06%5.23%4.72%2.28%
1 Month Performance3.26%3.69%9.87%3.39%
1 Year Performance-15.45%-11.05%12.42%7.45%

Addus HomeCare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BTSG
BrightSpring Health Services
0 of 5 stars
$10.43
-2.6%
$16.39
+57.1%
N/A$1.79B$8.42B0.0035,000Analyst Upgrade
News Coverage
AHCO
AdaptHealth
4.2333 of 5 stars
$7.24
-3.3%
$12.64
+74.6%
-53.3%$987.46M$2.97B-2.1210,900Analyst Report
Short Interest ↓
News Coverage
EHAB
Enhabit
0.4992 of 5 stars
$9.26
-4.4%
$12.80
+38.2%
-40.7%$464.20M$1.08B-6.9111,000Upcoming Earnings
Short Interest ↑
News Coverage
Positive News
AVAH
Aveanna Healthcare
0.2284 of 5 stars
$2.28
-4.6%
$1.78
-21.9%
+94.3%$434.86M$1.79B-1.233,700
AMED
Amedisys
2.319 of 5 stars
$93.69
+0.4%
$103.22
+10.2%
+2.6%$3.06B$2.22B1,338.6220,000Analyst Report
OPCH
Option Care Health
4.818 of 5 stars
$33.45
-1.4%
$37.17
+11.1%
+2.6%$5.92B$3.94B23.728,058Earnings Report
Insider Buying
Analyst Revision
Positive News
SLNO
Soleno Therapeutics
3.7857 of 5 stars
$48.89
+3.3%
$55.60
+13.7%
+2,557.9%$1.49BN/A-15.1825
PRTA
Prothena
3.6174 of 5 stars
$27.53
-1.7%
$69.89
+153.9%
-46.9%$1.48B$91.37M-9.83127Gap Down
STAA
STAAR Surgical
4.7408 of 5 stars
$30.79
-0.2%
$47.75
+55.1%
-43.9%$1.50B$284.39M78.95882Earnings Report
Analyst Report
News Coverage
Gap Down
AGIO
Agios Pharmaceuticals
1.2469 of 5 stars
$27.10
+2.2%
$34.00
+25.5%
+33.3%$1.52B$26.82M-4.27389

Related Companies and Tools

This page (NASDAQ:ADUS) was last updated on 2/29/2024 by MarketBeat.com Staff